| Alyssa Searles Daniel, MD | |
|
6324 Fairview Rd Ste 200, Charlotte, NC 28210-3361 | |
| (980) 302-9700 | |
| (980) 302-9730 |
| Full Name | Alyssa Searles Daniel |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 14 Years |
| Location | 6324 Fairview Rd Ste 200, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013233352 | NPI | - | NPPES |
| 1013233352 | Medicaid | NC | |
| NC2200 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 165244 (North Carolina) | Secondary |
| 207N00000X | Dermatology | 2014-00838 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metrolina Dermatology And Skin Surgery Specialists Pllc | 3173891892 | 7 |
News Archive
According to new international research, just less than one per cent of the population is naturally protected against developing chronic coronary artery diseases.
The most recent complete data for England (2014/15) shows an average uptake of the guaiac Faecal Occult Blood Tests (gFOBT) from those invited by the NHS Bowel Cancer Screening Programme (BCSP) of 58.22%.
The New York Times: Johnson & Johnson has said it will "revamp its quality controls, creating a single framework for its drug, medical device and consumer health care divisions." The move comes after the drugmaker saw a number of recalls of its medicines, such as Tylenol and Motrin, as well as probes by a congressional committee and the FDA into actions at its McNeil Consumer Healthcare subsidiary.
A species of a lipid that naturally helps skin injuries heal appears to also aid repair of common corneal injuries, even when other conditions, like diabetes, make healing difficult, scientists report.
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
› Verified 3 days ago
| Entity Name | Metrolina Dermatology And Skin Surgery Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619400033 PECOS PAC ID: 3173891892 Enrollment ID: O20170621000070 |
News Archive
According to new international research, just less than one per cent of the population is naturally protected against developing chronic coronary artery diseases.
The most recent complete data for England (2014/15) shows an average uptake of the guaiac Faecal Occult Blood Tests (gFOBT) from those invited by the NHS Bowel Cancer Screening Programme (BCSP) of 58.22%.
The New York Times: Johnson & Johnson has said it will "revamp its quality controls, creating a single framework for its drug, medical device and consumer health care divisions." The move comes after the drugmaker saw a number of recalls of its medicines, such as Tylenol and Motrin, as well as probes by a congressional committee and the FDA into actions at its McNeil Consumer Healthcare subsidiary.
A species of a lipid that naturally helps skin injuries heal appears to also aid repair of common corneal injuries, even when other conditions, like diabetes, make healing difficult, scientists report.
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alyssa Searles Daniel, MD Po Box 60447, Charlotte, NC 28260-0447 Ph: (980) 302-9700 | Alyssa Searles Daniel, MD 6324 Fairview Rd Ste 200, Charlotte, NC 28210-3361 Ph: (980) 302-9700 |
News Archive
According to new international research, just less than one per cent of the population is naturally protected against developing chronic coronary artery diseases.
The most recent complete data for England (2014/15) shows an average uptake of the guaiac Faecal Occult Blood Tests (gFOBT) from those invited by the NHS Bowel Cancer Screening Programme (BCSP) of 58.22%.
The New York Times: Johnson & Johnson has said it will "revamp its quality controls, creating a single framework for its drug, medical device and consumer health care divisions." The move comes after the drugmaker saw a number of recalls of its medicines, such as Tylenol and Motrin, as well as probes by a congressional committee and the FDA into actions at its McNeil Consumer Healthcare subsidiary.
A species of a lipid that naturally helps skin injuries heal appears to also aid repair of common corneal injuries, even when other conditions, like diabetes, make healing difficult, scientists report.
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
› Verified 3 days ago
Dr. Coleman Eric Altman, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2630 E Seventh St, Suite 200, Charlotte, NC 28204 Phone: 704-364-6110 Fax: 704-364-4245 | |
Sam Wu, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 309 S Sharon Amity Rd Ste 200, Charlotte, NC 28211 Phone: 704-344-8846 | |
Dr. Deborah Gardner Nixon, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8936 Blakeney Professional Dr, Charlotte, NC 28277 Phone: 704-341-0090 Fax: 704-341-0092 | |
Dr. Curtis Wayne Schupbach, MD Dermatology Medicare: Medicare Enrolled Practice Location: 2620 E 7th St, Charlotte, NC 28204 Phone: 704-358-9900 Fax: 704-344-0105 | |
Daren Diiorio, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4525 Cameron Valley Pkwy, Ste 2100, Charlotte, NC 28211 Phone: 704-355-5100 | |
Dr. Marc Alan Darst, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 11301 Golf Links Dr N, Suite 203, Charlotte, NC 28277 Phone: 704-321-3376 Fax: 704-541-6558 | |
Jonathan M Olson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 15830 Ballantyne Medical Pl, Suite 225, Charlotte, NC 28277 Phone: 704-919-1105 Fax: 704-910-3163 |